Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cerebral toxoplasmosis]

E Ribera Pascuet1, J López Aldeguer, M J Pérez Elías

  • 1Hospital Vall d'Hebron, Barcelona. eribera@hg.vhebron.es

Enfermedades Infecciosas Y Microbiologia Clinica
|December 22, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dolutegravir/lamivudine in virologically suppressed female participants: week 48 data from the pooled TANGO and SALSA studies.

HIV medicine·2024
Same author

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

The Journal of antimicrobial chemotherapy·2019
Same author

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

The Journal of antimicrobial chemotherapy·2019
Same author

Out of focus: tailoring the cascade of care to the needs of women living with HIV.

HIV medicine·2017
Same author

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same author

Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012).

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2015
Same journal

New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons.

Enfermedades infecciosas y microbiologia clinica·2025
Same journal

[Description of 12 HIV-positive patients who have had the COVID-19 in our area].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[SARS-CoV-2 infection as trigger multisystem inflammatory syndrome?]

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

Impact of COVID-19 on Madrid hospital system.

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

[COVID-19 and influenza A coinfection: a matter of principle].

Enfermedades infecciosas y microbiologia clinica·2024
Same journal

COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization.

Enfermedades infecciosas y microbiologia clinica·2024
See all related articles

Toxoplasmic encephalitis, a serious infection, requires prompt diagnosis and treatment. Advanced diagnostic tools and specific drug regimens, like pyrimethamine and sulfadiazine, are crucial for managing this condition.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Medical Diagnostics

Context:

  • Toxoplasmic encephalitis presents significant mortality and morbidity.
  • Diagnosis is challenging due to non-specific clinical and radiological findings.
  • Prompt treatment initiation is common upon suspicion of toxoplasmosis.

Purpose:

  • To outline diagnostic strategies for toxoplasmic encephalitis.
  • To detail recommended treatment regimens and alternatives.
  • To discuss diagnostic utility of SPECT and PCR in specific cases.

Summary:

  • Brain biopsy is considered for non-responsive or ambiguous cases.
  • SPECT with 201TI and PCR for T. gondii or Epstein-Barr virus aid diagnosis.
  • First-line treatment involves pyrimethamine and sulfadiazine for 6-8 weeks.

Related Experiment Videos

Impact:

  • Effective management strategies improve patient outcomes.
  • Accurate diagnosis prevents delayed or incorrect treatment.
  • Understanding treatment options and toxicities is vital for patient care.